Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The designation covers first-line advanced or metastatic biliary tract cancer. It is the program’s second Fast Track, and the FDA urged prompt talks on U.S. registration plans for the chemotherapy combination.
The designation covers first-line advanced or metastatic biliary tract cancer. Leads Biolabs said this is the drug’s second FDA Fast Track designation.